2. Objectives:
1. Introduction
2. Classification
3. What is the Dengue Virus?
4. Epidemiology
5. Morphology of Dengue virus
6. Pathogenesis
7.Target tissues
8.Vector of Dengue virus
9.Symptoms
10.Morbidity and Mortality
11.Diagnostic tests
12.Treatment 13.Prevention
3. Objectives:
1. Introduction 11. Diagnostic tests
2. Classification treatment
3. What is the Dengue Virus? Prevention
4. Epidemiology
5. Morphology of Dengue virus
6. Pathogenesis
7. Target tissues
8. Vector of Dengue virus
9. Symptoms
10. Morbidity and Mortality
4. Introduction
Dangue virus (DENV) is the cause of dengue fever
It is a mosquito-borne disease
It is single positive-stranded RNA virus
Five serotypes of the virus have been found
All of which cause the full spectrum of disease
6. What is the Dengue Virus?
It is Arbovirus, it can transmitted through arthropods i.e. mosquitoes
Aedes aegypti is a vector for Dengue virus
It is a pathogen that causes
Break bone fever and dandy fever
Dengue hemorrhagic fever (DHF)
Can lead to Dengue shock syndrome (DSS)
7. Most these disease are cause by four different serotypes (DEN-
1,2,3,4)
First reported epidemics in 1780 in Asia, Africa, and North America
9. Dengue became a world wide problem in the 1950’s
though it rarely affects the US.
10. Morphology of Dengue virus
Its is an enveloped virus
It has a roughly spherical shape
It is ssRNA virus
It has E and M protein on
envelope membrane
11. E protein are found as a dimer on the surface of the mature viral
particle
It is important in the initial attachment of this particle to the host cell
M (membrane) protein, which is important in the formation and
maturation of the viral particle
12. Pathogenesis
Humans are initially infected through a mosquito vector
Initial interaction with cell occurs with the viruses ability to
infect cell
Primary target, Phagocytes
Virus uses cell receptor molecule to enter cell
Cell receptor molecules include:
Glycosaminoglycan
Heparan Sulfate (Expressed in almost all cell types)
13. Virus replicates in target organs
Virus is released and circulates in blood
Alternate mosquito then bites host and receives virus
14. Target tissues
Dengue induces cytokine production in cells
Cytotoxic factor effects endothelial cells involved in most of the following:
Heart
Liver
Kidneys
Lungs
Intestines
Spleen
Lymph node
Brain
Skin (inflammatory rashes)
15. Vector of Dengue virus
Its vector is female Aedes aegypti.
Characteristics of the
Aedes Mosquito:
One distinct physical feature – black and white
stripes on its body and legs.
Bites during the day.
Lays its eggs in clean, stagnant water.
Close-up of an Aedes mosquito
16. Only the female Aedes mosquito feeds on blood
They need the protein found in blood to produce
eggs.
Male mosquitoes feed only on plant nectar.
On average, a female Aedes mosquito can lay
about 300 eggs during her life span of 14 to 21
days.
17. Life cycle of the Aedes Mosquito
1-2 days
Stagnant water
Pupae
4-5 days
Larvae Eggs
2-3 days
18. How Do Aedes Mosquitoes Transmit
Diseases...
Mosquito bites and sucks
blood containing the virus
from an infected person.
Virus is carried in its
body.
And passes the virus
to healthy people
when it bites them.
19. Symptoms
Fever
Headache
Muscle and joint pain
Dehydration
Nausea and/or Hematemesis (vomiting of blood)
Epistaxis (Bleeding from the nose, mouth,
or gums)
Haematuria (Blood in Urine)
Pain behind the eyes
Respiratory distress
Petechia (Skin rash) and/or Purpura (Lesions)
21. Morbidity and Mortality
More than 2.5 Billion people live in areas that have a risk of
infection
Over 100 million cases of Dengue infection are reported each year
globally
500,000 cases pertain to DHF
DHF has a 5% fatality rate for those infected
People at high risk are children and the elderly
22. Diagnostic tests
Virus isolation by infection of mice using infected mosquitoes
Detection of IgM antibodies in the blood by PCR or Viral isolation
(Serology)
ELISA (Enzyme-Linked Immunoabsorbent assay)
Stripe test
23. Treatment
There is no specific treatment
Symptomatic treatment is possible
Vaccination
Only one vaccine for dengue is currently approved in three countries
(Brazil, Mexico, Philippines).
Several vaccines are under development by private and public
researchers
Developing a vaccine against the disease is challenging
24. With four different serotypes of the dengue virus that can cause
the disease, the vaccine must immunize against all four types to
be effective.
Vaccination against only one serotype could possibly lead to
severe dengue hemorrhagic shock (DHS) when infected with
another serotype due to antibody-dependent enhancement.
When infected with dengue virus, the immune system produces
cross-reactive antibodies that provide immunity to that particular
serotype.
25. However, these antibodies are incapable of neutralizing other
serotypes .
Upon reinfection and actually increase viral replication.
When macrophages consume the ‘neutralized’ virus, the virus is able
to replicate within the macrophage, causing disease
These cross-reactive, ineffective antibodies ease access of virus into
macrophages, which induces more severe disease (dengue
hemorrhagic fever, dengue shock syndrome).
26. Prevention
Prevent Aedes from Breeding!
Remove ALL sources of stagnant water.
Deny the Aedes mosquito of any chance
to breed.